Novo medicamento reduz em muito os níveis de colesterol e ajuda doentes cardíacos (novo estudo que custou mil milhões):
https://mobile.nytimes.com/2017/03/17/health/cholesterol-drugs-repatha-amgen-pcsk9-inhibitors.html?_r=0
Citando:
"The drug, Repatha, is called a PCSK9 inhibitor and can make cholesterol tumble to levels almost never seen naturally in adults, or even in people taking cholesterol-lowering statins. The Amgen drug and a similar one, sold by Sanofi and Regeneron, were approved by the Food and Drug Administration in 2015 with the hope — and expectation — that they would lower the risk of heart attacks and strokes, and not just reduce levels of LDL cholesterol, the dangerous kind.
That hope has now been realized for the Amgen drug."
Outras fontes:
https://www.theguardian.com/society/2017/mar/18/drug-which-cuts-bad-cholesterol-can-help-prevent-heart-attacks-and-strokes
Editado: segunda fonte.